Cystografin Injection, Solution
Product Images NDC 0270-0149

2 FDA label images from Bracco Diagnostics Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cystografin (NDC 0270-0149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cystografin 100 mL Label (Cystografin 100ml Bottlelabel)

Cystografin 100 mL Label (Cystografin 100ml Bottlelabel)
Label for Cystografin diatrizoate meglumine injection USP 30%, 100 mL solution for intravenous use. The label specifies 14% organically bound iodine and usage for retrograde cystourethrography. It includes manufacturer Bracco Diagnostics and the NDC 0270-0149-60. The label also contains dosage instructions and a barcode.*
FDA Label Image

Cystografin 1 Box 10 Bottles — 300 mL (Image1box10bottles)

Cystografin 1 Box 10 Bottles — 300 mL (Image1box10bottles)
Label for Cystografin 300 mg/mL injection solution, diatrizoate meglumine 30%, manufactured for Bracco Diagnostics Inc. The label states 14% organically bound iodine, 10 bottles per box, with 300 mL each. It includes usage instructions, storage conditions, and identifies the product as Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.